VIASURE Viral Particles

VIASURE Viral Influenza B Positive Control Kit

VIASURE Viral Influenza B Positive Control Kit is based on RNA viral particles from Influenza B virus.

This control is intended for monitoring the whole process, from nucleic acid extraction to amplification with all nucleic acid detection assays designed for Influenza B identification.

Datasheet

Description

VIASURE Viral Influenza B Positive Control Kit is intended for monitoring the whole reverse transcription quantitative real-time PCR (RT-qPCR) process, from nucleic acid extraction to reverse transcription and amplification steps.

VIASURE Viral Influenza B Positive Control Kit contains non-replicative and non-infectious Influenza B viral particles that are expected to be processed along with respiratory samples from individuals with clinical suspicion of Influenza B infection.

This Kit is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in molecular techniques and in vitro diagnostic procedures.

Specifications

  • Inactivated viral particles. Non-infectious & Non replicatives.

  • Lyophilized presentation: transport and store at room temperature with a shelf life of 24 months.

  • Monodose format for nucleic acid detection techniques.

  • Final concentration range quantified by digital PCR: 11.000-110.000 copies per vial.

  • It contains the complete genome of the virus, the RNA sequence is homologous to the isolate B/Arizona/12/2020, belonging to Influenza B lineage Yamagata (GenBank accession numbers MT499475-82, sequence submitted by the World Health Organization -WHO-).

Do you need more info?

Contact